Next Article in Journal
Separating the Wheat from the Chaff: The Use of Upstream Regulator Analysis to Identify True Differential Expression of Single Genes within Transcriptomic Datasets
Previous Article in Journal
Ozone Induced Stomatal Regulations, MAPK and Phytohormone Signaling in Plants
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Caffeoyl-Prolyl-Histidyl-Xaa Derivatives and Evaluation of Their Activities and Stability upon Long-Term Storage

1
Department of Chemical and Biological Engineering, Sookmyung Women’s University, Seoul 04310, Korea
2
School of Chemical and Biological Engineering, Seoul National University, Seoul 08826, Korea
3
Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Korea
4
BeadTech Inc., 10-dong 4th, 49 Wonsi-ro, Danwon-gu, Ansan-si 15610, Korea
5
Industry Collaboration Center, Sookmyung Women’s University, Seoul 04310, Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to the work.
Int. J. Mol. Sci. 2021, 22(12), 6301; https://doi.org/10.3390/ijms22126301
Submission received: 21 May 2021 / Revised: 6 June 2021 / Accepted: 7 June 2021 / Published: 11 June 2021
(This article belongs to the Section Molecular Pharmacology)

Abstract

:
Antioxidants play a critical role in the treatment of degenerative diseases and delaying the aging of dermal tissue. Caffeic acid (CA) is a representative example of the antioxidants found in plants. However, CA is unsuitable for long-term storage because of its poor stability under ambient conditions. Caffeoyl-Pro-His-NH2 (CA-Pro-His-NH2, CA-PH) exhibits the highest antioxidant activity, free radical scavenging and lipid peroxidation inhibition activity among the histidine-containing CA-conjugated dipeptides reported to date. The addition of short peptides to CA, such as Pro-His, is assumed to synergistically enhance its antioxidative activity. In this study, several caffeoyl-prolyl-histidyl-Xaa-NH2 derivatives were synthesized and their antioxidative activities evaluated. CA-Pro-His-Asn-NH2 showed enhanced antioxidative activity and higher structural stability than CA-PH, even after long-term storage. CA-Pro-His-Asn-NH2 was stable for 3 months, its stability being evaluated by observing the changes in its NMR spectra. Moreover, the solid-phase synthetic strategy used to prepare these CA-Pro-His-Xaa-NH2 derivatives was optimized for large-scale production. We envision that CA-Pro-His-Xaa-NH2 derivatives can be used as potent dermal therapeutic agents and useful cosmetic ingredients.

1. Introduction

Reactive oxygen species (ROS) include highly reactive free radicals, such as peroxide (ROO) and superoxide (O2). ROS induce oxidative stress in the human body via radical chain reactions, thereby causing damage to DNA or RNA, cancer, chronic disease and aging [1,2]. In addition, oxidative stress can cause degenerative diseases such as Alzheimer’s disease [3,4,5].
Natural antioxidants found in various foods, including vegetables, meat, fruits and grains, inhibit the activity of ROS. They are considered suitable agents for scavenging radicals but are unsuitable for practical use as antioxidative nutrients or therapeutic agents because of their low concentration and/or activity [6,7]. Therefore, many synthetic antioxidants have been studied to prevent food corruption, delay the aging process, and treat degenerative diseases via scavenging ROS [8,9,10,11]. However, there are restrictions on the use of synthetic antioxidants, such as tertiary butylhydroquinone (TBHQ), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and bisphenol (BP), because they are potentially cytotoxic when used in high concentrations [12].
Phenolic compounds have been extensively studied as antioxidants because they provide a relatively stable free-radical structure after losing a hydrogen atom. Previous reports have shown that the antioxidant activity of phenolic compounds increases upon increasing the number of hydroxyl and methoxy groups on the phenyl ring [13]. Caffeic acid (CA, 3,4-dihydroxycinnamic acid) is a member of the hydroxycinnamic acid (HCA) family and is often found in nature. CA exhibits high antioxidant activity because of the delocalization of non-covalent electrons in its extended side chain [14]. In addition, the ortho-dihydroxyl group in CA forms a stable hydrogen bond after dissociation of the O-H bond [15,16,17]. To date, various CA derivatives, such as CA-triazole, CA-tyramine and CA-amino phenol, have been studied. However, such CA derivatives have insufficient redox-active catechol moiety or participate in side reactions, which decrease the antioxidative activity [18,19,20].
We have previously reported that the conjugation of CA to a peptide can enhance its stability. In particular, CA-Pro-His-NH2 exhibits the highest antioxidant activity reported to date because the s-cis proline conformer contributes to the increased antioxidant activity of CA (Figure 1) [21,22,23,24,25,26]. In this study, we expected that some of the CA-tripeptide derivatives would exhibit better antioxidant activity and stability than CA-Pro-His-NH2. Therefore, several CA-Pro-His-Xaa-NH2 derivatives were synthesized as an extended library from CA-Pro-His-NH2, and their antioxidant activity and long-term storage stability were evaluated.

2. Results and Discussion

2.1. Synthesis of CA-PHX-NH2

Several CA-PHX-NH2 derivatives were synthesized on Rink amide aminomethyl polystyrene (AM PS) resin using Fmoc-chemistry-based solid-phase peptide synthesis (SPPS) (Scheme 1). Prior to coupling CA to the peptides on the resin, the purity of the PHX-NH2 synthesized on the resin was determined using high-performance liquid chromatography (HPLC) after a small-scale cleavage reaction. The HPLC analysis showed that the purity of PHX-NH2 synthesized using Rink amide AM PS resin was >93%. The effect of the resin on the purity of PHX-NH2 was evaluated by synthesizing PHX-NH2 using Rink amide 4-methylbenzhydrylamine (MBHA) resin, which is known to result in higher purity during SPPS [27]. Unexpectedly, the Rink amide AM PS resin gave an approximately two-fold higher yield than Rink amide MBHA resin, as well as a 3–7% higher crude purity for all the compounds studied (Table 1). The Rink amide MBHA resin released the fragment of Rink amide linker as well as the tripeptide products during the final cleavage step, whereas Rink amide AM PS did not release any compound except the tripeptide products. This affected the purity and yield of the tripeptide products observed during HPLC when the peptides were synthesized on Rink amide MBHA resin.
Thus, several CA-PHX-NH2 derivatives were synthesized on Rink amide AM PS resin and obtained as white powders upon precipitation of the cleaved product using cold diethyl ether with crude purities in the range of 72–79%, as confirmed by ESI-MS (Table 2). Finally, the CA-PH-NH2 and CA-PHX-NH2 derivatives were obtained with >96% purity using preparative HPLC (Supplementary Figures S1–S11). The purified products were used for further investigation of their antioxidant activity.

2.2. Antioxidative Activities of the CA-PHX-NH2 Derivatives

2.2.1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Test

The free-radical scavenging activity (RSA) of the purified CA-PHX-NH2 derivatives was evaluated using a DPPH radical scavenging test. When the CA-PHX-NH2 derivatives were in their radical form after donating a hydrogen atom to DPPH, the color of the DPPH solution in methanol (MeOH) changed from purple to yellow (Supplementary Figure S12), and the absorbance observed at 516 nm decreased. Figure 2 shows the observed RSA (%) values, which were calculated using the following equation:
RSA (%) = (1 − Abs. of sample/Abs. of control) × 100.
Some of the CA-PHX-NH2 derivatives exhibited higher RSA (%) values than CA-PH-NH2, in the following order: CA-PHN-NH2 (92.5) > CA-PHF-NH2 (87.2) ≈ CA-PHA-NH2 (85.2) ≈ CA-PHD-NH2 (85.1) ≈ CA-PHG-NH2 (83.5) > CA-PHQ-NH2 (70.8) ≈ CA-PHS-NH2 (69.2) ≈ CA-PHK-NH2 (69.0) > CA-PH-NH2 (65.5) > CA-PHE-NH2 (62.7) > CA-PHR-NH2 (56.1). The various side chains of the amino acids influenced the coordination with catechol moiety in CA-PHX-NH2, which resulted in different antioxidant activities. CA-PHN-NH2 exhibited the highest RSA (%) value when compared to CA-PHX-NH2 and CA-PH-NH2. The addition of asparagine further stabilized the oxidation state of CA-PH-NH2. We presume that the antioxidant activity was improved by the amide side chain of asparagine coordinating precisely with the redox-active catechol moiety in CA-PHN-NH2. Further research would clarify the structure of the oxidation state of CA-PHN-NH2.

2.2.2. Lipid Peroxidation (LPO) Test

The antioxidant activity was also measured using a lipid peroxidation (LPO) inhibition assay using Tween 20-emulsified linoleic acid (Supplementary Figure S13). The percentage of lipid peroxidation inhibition (%Pi) was calculated using the following equation:
%Pi = (1 − Abs. of sample/Abs. of control) × 100.
The %Pi values observed for the CA-PHX-NH2 derivatives and CA-PH-NH2 decreased in the following order after 24 h: CA-PHR-NH2 (86.2) > CA-PHK-NH2 (86.1) > CA-PHS-NH2 (85.5) > CA-PHF-NH2 (85.1) > CA-PHE-NH2 (85.0) > CA-PHG-NH2 (84.7) > CA-PHQ-NH2 (84.0) > CA-PHA-NH2 (80.2) > CA-PH-NH2 (78.6) > CA-PHN-NH2 (74.9) > CA-PHD-NH2 (70.7). Figure 3 shows that most of the CA-PHX-NH2 derivatives were superior to CA-PH-NH2 in the LPO inhibition assay. Hydrophilic DPPH and hydrophobic LPO tests showed different patterns for the antioxidant activity among the caffeoyl peptide derivatives studied. For example, CA-PHN-NH2 showed the highest antioxidant activity in the DPPH test but had a lower activity than CA-PH-NH2 in the LPO inhibition assay. These differences can be attributed to the different solubilities of the derivatives in the working solutions used.

2.3. Cytotoxicity of the CA-PHX-NH2 Derivatives

The MTT assay data exhibited no significant cytotoxicity for the CA-PHX-NH2 derivatives at low concentration (1 µM). Even at concentrations as high as 100 µM, most of the CA-PHX-NH2 derivatives were not cytotoxic, while some of the compounds, such as CA-PHA-NH2, CA-PHR-NH2 and CA-PHK-NH2, showed cell viabilities of <80%. In the case of CA-PH-NH2, CA-PHS-NH2, CA-PHN-NH2 and CA-PHQ-NH2, cell viabilities exceeded 100%. We presume that those CA derivatives reduced the oxidative stress of the cells and promoted cell proliferation, overcoming cytotoxicity (Figure 4). Thus, CA-PHX-NH2 derivatives exhibiting low cytotoxicity have potential use as cosmetic ingredients.

2.4. Stability Evaluation Using 1H-NMR Spectroscopy

1H-NMR spectroscopy was used to evaluate the long-term structural stability of CA-PHN-NH2. The changes in the molar ratio of s-cis Pro, which demonstrates the stability of CA-PHN-NH2, were monitored upon storage at 25 °C under dark conditions over 3 months. The ratio of the s-cis form remained >93% for 3 months (Table 3, Supplementary Figure S14). The 1H-NMR spectra show that CA-PHN-NH2 exhibited limited transition between the cis and trans conformations over 3 months, which is critical for maintaining its high antioxidation activity [26]. Therefore, CA-PHN-NH2 will likely maintain its antioxidant activity in hydrophilic solutions upon long-term storage.

3. Materials and Methods

3.1. Materials

Triisopropylsilane (TIPS), caffeic acid (CA), 2,2-diphenyl-1-picrylhydrazyl (DPPH), linoleic acid, thiazolyl blue tetrazolium bromide (MTT), ammonium thiocyanate, Tween 20, sodium phosphate dibasic dodecahydrate, sodium phosphate monobasic dihydrate, ethanol (EtOH) and iron(II) chloride tetrahydrate (FeCl2·4H2O) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Functionalized resins, 9-fluorenylmethyloxycarbonyl (Fmoc)-Rink amide linker, Fmoc amino acids, N,N′-diisopropylcarbodiimde (DIC), N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uranium hexafluorophosphate (HBTU), 1-hydroxybenzotriazole (HOBt) and filtered reaction tubes (Libra tube®) were purchased from BeadTech Inc. (Ansan, Korea). Acetonitrile (ACN), dichloromethane (DCM), N,N-diisopropylethylamine (DIPEA), methanol (MeOH), N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), acetic anhydride, hydrochloric acid (HCl), piperidine, trifluoroacetic acid (TFA) and phenol were purchased from Daejung Chemical & Metals Co. Ltd. (Siheung, Korea). NIH 3T3 mouse fibroblasts were purchased from Korea Cell Line Bank (Seoul, Korea) and cultured in 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) penicillin streptomycin in RPMI 1640 media (Biowest, Nuaillé, France) at 37 °C in a humidified 5% CO2 atmosphere. Trypsin-ethylenediaminetetraacetic acid (EDTA) in Hanks’ balanced salt solution (HBSS) was purchased from Biowest (Nuaillé, France).

3.2. Solid-Phase Synthesis of CA-PHX-NH2

Prolyl-histidyl-Xaa-NH2 was synthesized on two types of resin using Fmoc/t-Bu chemistry. The tripeptides were synthesized on a Rink amide resin (300 mg) by repeating the coupling and deprotection steps: (a) in the coupling step, the resins were treated with a solution of Fmoc-amino acid (3.0 equiv.), HBTU (3.0 equiv.), HOBt (3.0 equiv.) and DIPEA (6.0 equiv.) in DMF (10 mL) for 2 h; (b) in the deprotection step, each resin was treated twice with 20% piperidine/DMF (v/v) solution (2 × 10 mL) for 5 and 10 min. The resins were washed with DMF, DCM and MeOH three times after each coupling and deprotection step. The completion of each amino acid coupling reaction used in the synthesis was confirmed using Kaiser’s ninhydrin test.
The CA (3.0 equiv.) was dissolved in DMF (3 mL) in a glass vial. To this solution, HOBt (3.0 equiv.) and DIC (3.0 equiv.) were added, and the resulting mixture was stirred at room temperature for 30 min under dark conditions. The mixture was added to a reaction tube containing Pro-His-Xaa-NH2 and DIPEA (6.0 equiv.) and incubated in a multirotator for 1 h at room temperature. The resin was washed three times with DMF, DCM and MeOH. The resin was treated with a cleavage cocktail comprising trifluoroacetic acid/phenol/triisopropylsilane/water (88:5:5:2, v/v/v/v; 3 mL) for 2 h. After removal of the resin, the resulting solution was precipitated upon the addition of diethyl ether. The supernatant was decanted after centrifugation, and the remaining pellet was washed three times with diethyl ether via centrifugation and dried in vacuo. The purities of the peptides and CA-PHX-NH2 were analyzed using HPLC under the following conditions: gradient elution with A (0.1% TFA in water) and B (0.1% TFA in acetonitrile) from 10% to 90% B over 41 min; flow rate of 1.0 mL/min; UV detection at 230 and 214 nm; column temperature of 35.0 °C.

3.3. Antioxidant Activities of CA-PHX-NH2

3.3.1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Test

A DPPH/MeOH solution (0.1 mM, 1.48 mL) was placed in a microtube and treated with a solution of the CA-PHX-NH2 derivative in MeOH (50 µM, 0.2 mL) for 10 min. The absorbance of the DPPH mixture was measured at 516 nm using a UV/Vis spectrophotometer [22].

3.3.2. LPO Test

A linoleic acid emulsion (25 mM) was prepared by mixing linoleic acid (142 mg), Tween 20 (142 mg) and sodium phosphate buffer (0.1 M, pH 7.0, 50 mL). As antioxidants of the linoleic acid emulsion, solutions of the CA-PHX-NH2 derivatives (9, 45 and 90 μM and 0.5 mL) were prepared in a mixture of water (0.5 mL) and sodium phosphate buffer (0.1 M, 2.0 mL) in separate vials for the LPO test. Each mixture was kept at 50 °C under dark conditions for 24 h [28,29]. Each mixture (25 μL) was mixed with 75% EtOH (1.175 mL), FeCl2·4H2O in 3.5% hydrochloric acid (HCl) (20 mM, 25 μL) and 25 μL of 30% NH4SCN for 3 min. The absorbance of the mixtures at 500 nm was measured using a UV/Vis spectrophotometer.

3.4. Cytotoxicity Assay for CA-PHX-NH2

NIH 3T3 cells were seeded (100,000 cells/mL, 200 μL) in a 96-well plate and incubated for 1 day. Solutions of each CA-PHX-NH2 derivative in RPMI 1640 media (1, 10, 50 and 100 μM) were prepared. The cell culture medium in each well was carefully aspirated, and the cells were treated with the CA-PHX-NH2 solutions for 1 day in a CO2 incubator. After removal of the solution, the cells were incubated in the presence of MTT solution (200 μL) for 3 h. After incubation, the MTT solution was discarded and DMSO was added to dissolve the formazan produced by the living cells. The mixtures in the 96-well plate were shaken in a shaking incubator for 20 min. The absorbance of the dissolved formazan was measured at a wavelength of 590 nm using a microplate reader. The percentage of cell viability was calculated by comparison with the number of standard cells which were not treated with the solutions of CA derivatives.

3.5. Long-Term Stability Test Using 1H-NMR Spectroscopy

The sample of CA-PHN-NH2 for 1H-NMR spectroscopy was prepared by dissolving 10 mg of compound (±0.01 mg) in 1 mL of methanol-d6 (MeOD). The resulting solution was transferred to a 5 mm standard NMR tube. The 1H-NMR spectra were obtained on a Bruker AVANCE III-HD500 spectrometer operated at 500 MHz. Tetramethylsilane (TMS) was used as an internal standard for the analysis of the chemical shifts.

4. Conclusions

A library of caffeoyl tripeptides (CA-PHX-NH2) was synthesized, and their antioxidant activities were evaluated to develop new CA-peptide derivatives with enhanced antioxidant capacity compared to CA-PH-NH2. The DPPH assay showed that CA-PHN-NH2 exhibited the highest free RSA (92.5%), compared to CA-PHX-NH2 and CA-PH-NH2. None of the CA derivatives exhibited significant cytotoxicity at concentrations up to 100 µM. 1H-NMR spectroscopy showed that CA-PHN-NH2 maintained its structural integrity for up to 3 months. Therefore, CA-PHN-NH2 is expected to be used as a raw material for pharmaceutical or cosmetic ingredients because of its superior antioxidant ability and long-term stability.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/article/10.3390/ijms22126301/s1. Figure S1. HPLC chromatograms of (a) crude CA-PH-NH2, (b) purified CA-PH-NH2, and (c) ESI-MS data of CA-PH-NH2, Figure S2. HPLC chromatograms of (a) crude CA-PHS-NH2, (b) purified CA-PHS-NH2, and (c) ESI-MS data of CA-PHS-NH2, Figure S3. HPLC chromatograms of (a) crude CA-PHR-NH2, (b) purified CA-PHR-NH2, and (c) ESI-MS data of CA-PHR-NH2, Figure S4. HPLC chromatograms of (a) crude CA-PHD-NH2, (b) purified CA-PHD-NH2, and (c) ESI-MS data of CA-PHD-NH2, Figure S5. HPLC chromatograms of (a) crude CA-PHG-NH2, (b) purified CA-PHG-NH2, and (c) ESI-MS data of CA-PHG-NH2, Figure S6. HPLC chromatograms of (a) crude CA-PHN-NH2, (b) purified CA-PHN-NH2, and (c) ESI-MS data of CA-PHN-NH2, Figure S7. HPLC chromatograms of (a) crude CA-PHF-NH2, (b) purified CA-PHF-NH2, and (c) ESI-MS of CA-PHF-NH2, Figure S8. HPLC chromatograms of (a) crude CA-PHK-NH2, (b) purified CA-PHK-NH2, and (c) ESI-MS of CA-PHK-NH2, Figure S9. HPLC chromatograms of (a) crude CA-PHE-NH2, (b) purified CA-PHE-NH2, and (c) ESI-MS data of CA-PHE-NH2, Figure S10. HPLC chromatograms of (a) crude CA-PHA-NH2, (b) purified CA-PHA-NH2, and (c) ESI-MS data of CA-PHA-NH2, Figure S11. HPLC chromatograms of (a) crude CA-PHQ-NH2, (b) purified CA-PHQ-NH2, and (c) ESI-MS data of CA-PHQ-NH2, Figure S12. Mechanism of the DPPH radical scavenging test, Figure S13. Mechanism of lipid peroxidation inhibition test, Figure S14. 1H-NMR spectra of CA-PHN-NH2 tripeptides for 3 months at room temperature in the dark.

Author Contributions

H.J. and Y.-E.J. designed and performed the experiments and analyzed the data. Y.-S.L. and D.-S.S. designed the experiments and analyzed the data. H.J., Y.-E.J., Y.-S.L. and D.-S.S. wrote the manuscript. J.-K.Y. and J.K. performed the experiments and analyzed the data. W.-J.C. analyzed the data and edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the research fund of the Industrial Strategic Technology Development Program (10077652) of the Ministry of Trade, Industry, and Energy (MOTIE), the Korean Evaluation Institute of Industrial Technology (KEIT) and the Basic Science Research Program through the National Research Foundation of Korea (NRF-2019R1F1A1062208).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

CA-PHX-NH2Caffeoyl-prolyl-histidyl-X amino acid amide
AM PSAminomethyl polystyrene
MBHA4-Methylbenzhydrylamine
DPPH2,2-Diphenyl-1-picrylhydrazyl
LPOLipid peroxidation

References

  1. Apel, K.; Hirt, H. Reactive oxygen species: Metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol. 2004, 55, 373–399. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Halliwell, B. Antioxidants in human health and disease. Annu. Rev. Nutr. 1996, 16, 33–50. [Google Scholar] [CrossRef] [PubMed]
  3. Benzi, G.; Moretti, A. Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol. Aging 1995, 16, 661–674. [Google Scholar] [CrossRef]
  4. Perry, G.; Castellani, R.J.; Hirai, K.; Smith, M.A. Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimer’s Dis. 1998, 1, 45–55. [Google Scholar] [CrossRef] [Green Version]
  5. Zhao, B. Natural antioxidants protect neurons in Alzheimer’s disease and Parkinson’s disease. Neurochem. Res. 2009, 34, 630–638. [Google Scholar] [CrossRef]
  6. Moure, A.; Cruz, J.M.; Franco, D.; Domínguez, J.M.; Sineiro, J.; Domínguez, H.; Núñez, M.J.; Parajó, J.C. Natural antioxidants from residual sources. Food Chem. 2001, 72, 145–171. [Google Scholar] [CrossRef]
  7. Pokorný, J. Are natural antioxidants better–and safer–than synthetic antioxidants? Eur. J. Lipid Sci. Technol. 2007, 109, 629–642. [Google Scholar] [CrossRef]
  8. Chen, Z.; Chan, P.; Kwan, K.; Zhang, A. Reassessment of the antioxidant activity of conjugated linoleic acids. J. Am. Oil Chem. Soc. 1997, 74, 749–753. [Google Scholar] [CrossRef]
  9. Shahidi, F. Antioxidants in food and food antioxidants. Food/Nahrung 2000, 44, 158–163. [Google Scholar] [CrossRef]
  10. Guan, Y.; Chu, Q.; Fu, L.; Ye, J. Determination of antioxidants in cosmetics by micellar electrokinetic capillary chromatography with electrochemical detection. J. Chromatogr. A 2005, 1074, 201–204. [Google Scholar] [CrossRef]
  11. Rayner, B.S.; Duong, T.H.; Myers, S.J.; Witting, P.K. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J. Neurochem. 2006, 97, 211–221. [Google Scholar] [CrossRef] [PubMed]
  12. Branen, A. Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene. J. Am. Oil Chem. Soc. 1975, 52, 59–63. [Google Scholar] [CrossRef] [PubMed]
  13. Wright, J.S.; Johnson, E.R.; DiLabio, G.A. Predicting the activity of phenolic antioxidants: Theoretical method, analysis of substituent effects, and application to major families of antioxidants. J. Am. Chem. Soc. 2001, 123, 1173–1183. [Google Scholar] [CrossRef] [PubMed]
  14. Graf, E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med. 1992, 13, 435–448. [Google Scholar] [CrossRef]
  15. Son, S.; Lewis, B.A. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: Structure—activity relationship. J. Agric. Food Chem. 2002, 50, 468–472. [Google Scholar] [CrossRef] [PubMed]
  16. Cheng, Z.; Ren, J.; Li, Y.; Chang, W.; Chen, Z. Study on the multiple mechanisms underlying the reaction between hydroxyl radical and phenolic compounds by qualitative structure and activity relationship. Bioorganic Med. Chem. 2002, 10, 4067–4073. [Google Scholar] [CrossRef]
  17. Shahidi, F.; Janitha, P.; Wanasundara, P. Phenolic antioxidants. Crit. Rev. Sci. Nutr. 1992, 32, 67–103. [Google Scholar] [CrossRef]
  18. Doiron, J.A.; Métayer, B.; Richard, R.R.; Desjardins, D.; Boudreau, L.H.; Levesque, N.A.; Jean-François, J.; Poirier, S.J.; Surette, M.E.; Touaibia, M. Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors. Int. J. Med. Chem. 2014, 2014. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Marinova, E.; Georgiev, L.; Totseva, I.; Seizova, K.; Milkova, T. Antioxidant activity and mechanism of action of some synthesised phenolic acid amides of aromatic amines. Czech J. Food Sci. 2013, 31, 5–13. [Google Scholar] [CrossRef] [Green Version]
  20. Rajan, P.; Vedernikova, I.; Cos, P.; Berghe, D.V.; Augustyns, K.; Haemers, A. Synthesis and evaluation of caffeic acid amides as antioxidants. Bioorganic Med. Chem. Lett. 2001, 11, 215–217. [Google Scholar] [CrossRef]
  21. Kwak, S.Y.; Seo, H.S.; Lee, Y.S. Synergistic antioxidative activities of hydroxycinnamoyl-peptides. J. Pept. Sci. Off. Publ. Eur. Pept. Soc. 2009, 15, 634–641. [Google Scholar] [CrossRef] [PubMed]
  22. Pekkarinen, S.S.; Stöckmann, H.; Schwarz, K.; Heinonen, I.M.; Hopia, A.I. Antioxidant activity and partitioning of phenolic acids in bulk and emulsified methyl linoleate. J. Agric. Food Chem. 1999, 47, 3036–3043. [Google Scholar] [CrossRef] [PubMed]
  23. Seo, H.-S.; Kwak, S.-Y.; Lee, Y.-S. Antioxidative activities of histidine containing caffeic acid-dipeptides. Bioorganic Med. Chem. Lett. 2010, 20, 4266–4272. [Google Scholar] [CrossRef] [PubMed]
  24. Spasova, M.; Kortenska-Kancheva, V.; Totseva, I.; Ivanova, G.; Georgiev, L.; Milkova, T. Synthesis of cinnamoyl and hydroxycinnamoyl amino acid conjugates and evaluation of their antioxidant activity. J. Pept. Sci. Off. Publ. Eur. Pept. Soc. 2006, 12, 369–375. [Google Scholar] [CrossRef] [PubMed]
  25. Stankova, I.; Chuchkov, K.; Shishkov, S.; Kostova, K.; Mukova, L.; Galabov, A.S. Synthesis, antioxidative and antiviral activity of hydroxycinnamic acid amides of thiazole containing amino acid. Amino Acids 2009, 37, 383–388. [Google Scholar] [CrossRef] [PubMed]
  26. Kwak, S.-Y.; Lee, H.J.; Yang, J.-K.; Lee, E.J.; Seo, M.; Lee, Y.-S. Antioxidant activity of caffeoyl-prolyl-histidine amide and its effects on PDGF-induced proliferation of vascular smooth muscle cells. Amino Acids 2014, 46, 2777–2785. [Google Scholar] [CrossRef]
  27. Matsueda, G.R.; Stewart, J.M. A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides. Peptides 1981, 2, 45–50. [Google Scholar] [CrossRef]
  28. Mitsuda, H. Antioxidative action of indole compounds during the autoxidation of linoleic acid. Eiyo Shokuryo 1966, 19, 210–221. [Google Scholar] [CrossRef] [Green Version]
  29. Chen, H.-M.; Muramoto, K.; Yamauchi, F. Structural analysis of antioxidative peptides from Soybean. beta.-Conglycinin. J. Agric. Food Chem. 1995, 43, 574–578. [Google Scholar] [CrossRef]
Figure 1. Antioxidant mechanism of CA-PH-NH2 with peroxyl radicals based on an H-atom transfer and single-electron transfer mechanism. Reproduced from [26], with permission of Springer Nature Limited.
Figure 1. Antioxidant mechanism of CA-PH-NH2 with peroxyl radicals based on an H-atom transfer and single-electron transfer mechanism. Reproduced from [26], with permission of Springer Nature Limited.
Ijms 22 06301 g001
Scheme 1. Solid-phase synthesis of the CA-PHX derivatives. Reagents and conditions: (a) Fmoc-L-amino acid (3 equiv.), HBTU (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (b) 20% piperidine/DMF (v/v), 5 and 10 min; (c) Fmoc-L-His-OH (3 equiv.), HBTU (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (d) repeat (b); (e) Fmoc-L-Pro-OH (3 equiv.), HBTU (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (f) repeat (b); (g) CA (3 equiv.), DIC (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (h) treatment of dry resin with cleavage cocktail (88% TFA/5% phenol/5% water/2% TIPS) for 1 h and precipitation using diethyl ether. R: side chain of amino acid (serine, arginine, aspartic acid, glycine, asparagine, phenylalanine, lysine, glutamic acid, alanine and glutamine).
Scheme 1. Solid-phase synthesis of the CA-PHX derivatives. Reagents and conditions: (a) Fmoc-L-amino acid (3 equiv.), HBTU (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (b) 20% piperidine/DMF (v/v), 5 and 10 min; (c) Fmoc-L-His-OH (3 equiv.), HBTU (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (d) repeat (b); (e) Fmoc-L-Pro-OH (3 equiv.), HBTU (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (f) repeat (b); (g) CA (3 equiv.), DIC (3 equiv.), HOBt (3 equiv.), DIPEA (6 equiv.), DMF, 2 h; (h) treatment of dry resin with cleavage cocktail (88% TFA/5% phenol/5% water/2% TIPS) for 1 h and precipitation using diethyl ether. R: side chain of amino acid (serine, arginine, aspartic acid, glycine, asparagine, phenylalanine, lysine, glutamic acid, alanine and glutamine).
Ijms 22 06301 sch001
Figure 2. DPPH radical scavenging activity of the CA-PHX-NH2 derivatives. Each experiment was performed in triplicate. Results are presented as mean ± standard error.
Figure 2. DPPH radical scavenging activity of the CA-PHX-NH2 derivatives. Each experiment was performed in triplicate. Results are presented as mean ± standard error.
Ijms 22 06301 g002
Figure 3. Antioxidant activity of the CA-PHX-NH2 derivatives under lipid peroxidation conditions. Each experiment was performed in triplicate. Results are presented as mean ± standard error.
Figure 3. Antioxidant activity of the CA-PHX-NH2 derivatives under lipid peroxidation conditions. Each experiment was performed in triplicate. Results are presented as mean ± standard error.
Ijms 22 06301 g003
Figure 4. Cytotoxicity of the CA-PHX-NH2 derivatives measured using MTT assay. Each experiment was performed in triplicate. Results are presented as mean ± standard error.
Figure 4. Cytotoxicity of the CA-PHX-NH2 derivatives measured using MTT assay. Each experiment was performed in triplicate. Results are presented as mean ± standard error.
Ijms 22 06301 g004
Table 1. Yields and purities of the representative tripeptides (PHX-NH2) synthesized using Rink amide MBHA resin and Rink amide AM PS resin.
Table 1. Yields and purities of the representative tripeptides (PHX-NH2) synthesized using Rink amide MBHA resin and Rink amide AM PS resin.
TripeptideRink Amide MBHA ResinRink Amide AM PS Resin
Yield (%)Purity (%)Yield (%)Purity (%)
PHS-NH249.489.789.696.2
PHA-NH257.594.082.297.4
PHN-NH249.590.0>9995.4
PHD-NH247.889.597.393.7
Table 2. Purity and ESI-MS results of CA-PHX-NH2.
Table 2. Purity and ESI-MS results of CA-PHX-NH2.
CA-PHX-NH2Crude Purity (%)Refinement Purity (%)ESI-MS
CalculatedFound
[M + H]+[M + H]+
CA-PH-NH274.698.2414.43414.02
CA-PHS-NH277.698.5501.49501.07
CA-PHR-NH276.397.4570.60570.00
CA-PHD-NH272.699.5529.5529.04
CA-PHG-NH273.497.1471.46471.03
CA-PHN-NH276.998.7528.51528.09
CA-PHF-NH279.999.2561.59561.02
CA-PHK-NH279.798.5542.58542.14
CA-PHE-NH275.997.7543.53543.04
CA-PHA-NH273.498.1485.49485.07
CA-PHQ-NH275.196.1542.54541.96
Table 3. Ratio of the s-cis form of CA-PHN-NH2.
Table 3. Ratio of the s-cis form of CA-PHN-NH2.
CA-PHN-NH2Relative Integral Intensity (%)
(Ratio of s-cis Form)
CH= ProtonHis Cε1-H ProtonAverage
0 h94.3894.6194.50
1 week93.8494.0193.93
1 month93.4094.2293.81
2 months95.0493.8294.43
3 months93.6995.5394.61
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Jeong, H.; Jeon, Y.-E.; Yang, J.-K.; Kim, J.; Chung, W.-J.; Lee, Y.-S.; Shin, D.-S. Synthesis of Caffeoyl-Prolyl-Histidyl-Xaa Derivatives and Evaluation of Their Activities and Stability upon Long-Term Storage. Int. J. Mol. Sci. 2021, 22, 6301. https://doi.org/10.3390/ijms22126301

AMA Style

Jeong H, Jeon Y-E, Yang J-K, Kim J, Chung W-J, Lee Y-S, Shin D-S. Synthesis of Caffeoyl-Prolyl-Histidyl-Xaa Derivatives and Evaluation of Their Activities and Stability upon Long-Term Storage. International Journal of Molecular Sciences. 2021; 22(12):6301. https://doi.org/10.3390/ijms22126301

Chicago/Turabian Style

Jeong, Hyeri, Young-Eun Jeon, Jin-Kyoung Yang, Jaehi Kim, Woo-Jae Chung, Yoon-Sik Lee, and Dong-Sik Shin. 2021. "Synthesis of Caffeoyl-Prolyl-Histidyl-Xaa Derivatives and Evaluation of Their Activities and Stability upon Long-Term Storage" International Journal of Molecular Sciences 22, no. 12: 6301. https://doi.org/10.3390/ijms22126301

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop